Page last updated: 2024-08-24

gemcitabine and leucine

gemcitabine has been researched along with leucine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chan, KS; Lim, KH; Lim, WT; Lynette, O; Montoya, J; Ng, QS; Sakktee Krisna, S; Takano, A; Tan, DS; Tan, EH	1
Hou, J; Huang, Y; Jiang, Y; Li, X; Wang, X; Wu, J; Xu, W; Zhang, J; Zhang, Y	1

Other Studies

2 other study(ies) available for gemcitabine and leucine

Article	Year
Molecular profiling for druggable genetic abnormalities in carcinoma of unknown primary. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, May-10, Volume: 31, Issue:14 Topics: Antineoplastic Combined Chemotherapy Protocols; Arginine; Biopsy; Carboplatin; Carcinoma; Deoxycytidine; Disease-Free Survival; ErbB Receptors; Gefitinib; Gemcitabine; Humans; Immunohistochemistry; Leucine; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm Staging; Neoplasms, Unknown Primary; Point Mutation; Quinazolines; Tomography, X-Ray Computed	2013
Discovery of a novel chimeric ubenimex-gemcitabine with potent oral antitumor activity. Bioorganic & medicinal chemistry, 2016, 11-15, Volume: 24, Issue:22 Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Aorta, Thoracic; Apoptosis; CD13 Antigens; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Dose-Response Relationship, Drug; Drug Discovery; Gemcitabine; Human Umbilical Vein Endothelial Cells; Humans; Leucine; Molecular Structure; Rats; Structure-Activity Relationship; Swine	2016

Article

Year

Molecular profiling for druggable genetic abnormalities in carcinoma of unknown primary.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, May-10, Volume: 31, Issue:14

Topics: Antineoplastic Combined Chemotherapy Protocols; Arginine; Biopsy; Carboplatin; Carcinoma; Deoxycytidine; Disease-Free Survival; ErbB Receptors; Gefitinib; Gemcitabine; Humans; Immunohistochemistry; Leucine; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm Staging; Neoplasms, Unknown Primary; Point Mutation; Quinazolines; Tomography, X-Ray Computed

2013

Discovery of a novel chimeric ubenimex-gemcitabine with potent oral antitumor activity.

Bioorganic & medicinal chemistry, 2016, 11-15, Volume: 24, Issue:22

Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Aorta, Thoracic; Apoptosis; CD13 Antigens; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Dose-Response Relationship, Drug; Drug Discovery; Gemcitabine; Human Umbilical Vein Endothelial Cells; Humans; Leucine; Molecular Structure; Rats; Structure-Activity Relationship; Swine

2016